Brokers Issue Forecasts for BDTX Q1 Earnings
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) – Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for shares of Black Diamond Therapeutics in a report issued on Friday, March 7th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($0.22) for the quarter. Wedbush currently has […]
